GRIN Grown Rogue International Inc.
Grown Rogue International Inc., through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States. It offers flower and flower pre-rolls, as well as flower-based products. The company also produces recreational marijuana and distributes it to dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Grown Rogue International (CNSX: GRIN)
›
Grown Rogue International (CNSX: GRIN) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.
The shares were at 0.4900 CAD on 19 November 2026, down 14.0% over 52 weeks. Its 52-week range is 0.3800 CAD to 0.7200 CAD: the price is 31.9% below the high and 28.9% above the low.
Its market capitalisation is 122.47M CAD.
Grown Rogue International reports return on equity of 8.3%, an operating margin of 0.2% and revenue up 29.4% year over year.
Its debt exceeds its cash by 40.11M USD, a debt-to-equity ratio of 1.28. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.